BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8888085)

  • 21. Comparison of pancuronium and vecuronium for fetal neuromuscular blockade during invasive procedures.
    Watson WJ; Atchison SR; Harlass FE
    J Matern Fetal Med; 1996; 5(3):151-4. PubMed ID: 8796786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Side effects and changes in pulmonary function after fixed dose precurarization with alcuronium, pancuronium or vecuronium.
    Motsch J; Fuchs W; Hoch P; Kaas V; Hutschenreuter K
    Br J Anaesth; 1987 Dec; 59(12):1528-32. PubMed ID: 2892518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the decreasing availability of vecuronium and pancuronium putting patients at risk?
    Church HL; Kong KL; North J
    Eur J Anaesthesiol; 2009 Apr; 26(4):347-8. PubMed ID: 19401668
    [No Abstract]   [Full Text] [Related]  

  • 25. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economic benefit of practice guidelines for stress ulcer prophylaxis.
    Mostafa G; Sing RF; Matthews BD; Pratt BL; Norton HJ; Heniford BT
    Am Surg; 2002 Feb; 68(2):146-50. PubMed ID: 11842960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porphyrinogenic effects of atracurium, vecuronium, and pancuronium in a primed rat model.
    Böhrer H; Schmidt H; Bach A; Martin E; Kohl B; Bolsen K; Goerz G
    Lab Anim Sci; 1994 Aug; 44(4):326-30. PubMed ID: 7983842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vecuronium.
    Dimens Crit Care Nurs; 1999; 18(5):23. PubMed ID: 10640038
    [No Abstract]   [Full Text] [Related]  

  • 30. Tachyphylaxis to cisatracurium--case reports and literature review.
    Haddad S
    Middle East J Anaesthesiol; 2008 Jun; 19(5):1079-92. PubMed ID: 18637607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five flaws in drug delivery.
    Cohen MR
    Nursing; 2007 Sep; 37(9):10. PubMed ID: 17728621
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influence of epidural lidocaine injection on vecuronium-induced neuromuscular blockade].
    Munakata K; Suzuki T; Watanabe N; Nagai H; Kakishita M; Saeki S; Ogawa S
    Masui; 2004 Dec; 53(12):1377-80. PubMed ID: 15682798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prolonged paralysis after long-term administration of vecuronium in the intensive care unit].
    Tanaka O; Akai H; Takekida S; Tanaka Y; Wake M; Iijima K; Horikawa Y; Ijichi K
    Masui; 2006 Aug; 55(8):992-4. PubMed ID: 16910480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisatracurium: a new nondepolarizing neuromuscular blocking agent.
    Owens CA; Brakoniecki J
    Conn Med; 1996 Aug; 60(8):461-3. PubMed ID: 8823977
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuromuscular blockage in emergency medicine.
    Panacek EA
    West J Med; 1991 Sep; 155(3):286-7. PubMed ID: 1683070
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance to nondepolarizing neuromuscular blocking agents.
    Tschida SJ; Graupe KJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1996; 16(3):409-18. PubMed ID: 8726599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vecuronium.
    Med Lett Drugs Ther; 1984 Nov; 26(674):102. PubMed ID: 6149453
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vecuronium as an adjunct treatment for neonatal tetanus: case report of 2 cases].
    Huang QM; You AP; Li YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):236-7. PubMed ID: 20350442
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-effective treatment of atracurium resistance in critically ill patients.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Am J Health Syst Pharm; 1995 Aug; 52(16):1818-9. PubMed ID: 8528843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.